Clinical trial

Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors

NCT00004979

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record topotecan hydrochloride Normalized identity: topotecan hydrochlorideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE1 / PHASE2

Conditions

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

paclitaxelDRUG · verified · RxNorm: paclitaxel

topotecan hydrochlorideDRUG · verified · RxNorm: topotecan hydrochloride

Sponsors & collaborators

Jonsson Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00004979 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.